Neil O'Neill Gilmore, CEO at Editas Medicine, Inc. (EDIT), sold 5,394 shares at $2.02 ($11K) on 2026-03-03, disclosed to the SEC on 2026-03-04.
Seasonal sale ($11k) by CEO — this insider has traded EDIT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| EDIT | SELL | 2025-12-04 | $12K | — | Filing → |
| EDIT | SELL | 2025-09-04 | $15K | — | Filing → |
| EDIT | SELL | 2025-06-04 | $26K | — | Filing → |